Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $249

Benzinga · 3d ago
Morgan Stanley analyst Sean Laaman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $247 to $249.